HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuromyelitis optica spectrum disorder presenting with repeated hypersomnia due to involvement of the hypothalamus and hypothalamus-amygdala linkage.

Abstract
We report the case of a 46-year-old Japanese woman with neuromyelitis optica spectrum disorder presenting with repeated hypersomnia accompanied by decreased CSF orexin level. First episode associated with hypothalamic-pituitary dysfunction showed bilateral hypothalamic lesions that can cause secondary damage to the orexin neurons. The second episode associated with impaired memory showed a left temporal lesion involving the amygdala. The mechanism remains unknown, but the reduced blood flow in the hypothalamus ipsilateral to the amygdala lesion suggested trans-synaptic hypothalamic dysfunction secondary to the impaired amygdala. A temporal lesion involving the amygdala and hypothalamus could be responsible for hypersomnia due to neuromyelitis optica spectrum disorder.
AuthorsKodai Kume, Kazushi Deguchi, Kazuyo Ikeda, Tadayuki Takata, Yohei Kokudo, Masaki Kamada, Tetsuo Touge, Toshiyuki Takahashi, Takashi Kanbayashi, Tsutomu Masaki
JournalMultiple sclerosis (Houndmills, Basingstoke, England) (Mult Scler) Vol. 21 Issue 7 Pg. 960-2 (Jun 2015) ISSN: 1477-0970 [Electronic] England
PMID25680985 (Publication Type: Case Reports, Journal Article)
Copyright© The Author(s), 2015.
Chemical References
  • Orexins
Topics
  • Amygdala (pathology)
  • Disorders of Excessive Somnolence (etiology)
  • Female
  • Humans
  • Hypothalamus (pathology)
  • Magnetic Resonance Imaging
  • Middle Aged
  • Neuromyelitis Optica (cerebrospinal fluid, complications, pathology)
  • Orexins (cerebrospinal fluid)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: